Lilly’s Omvoh Shows Broad One-Year Disease Control in Ulcerative Colitis and Crohn’s Disease New analyses from Eli Lilly suggest that patients with moderate to severe ulcerative colitis or Crohn’s disease treated with Omvoh, also known as mirikizumab, were able to meet several measures of disease control at the same time after one year of treatment. What the New Analyses Measured In ulcerative colitis, Lilly assessed a composite goal called comprehensive disease control. A pa

The U.S. Food and Drug Administration has granted approval to Roche’s Enspryng, also known as satralizumab, for adults living with thyroid eye disease. With this decision, patients may receive the medicine through an injection under the skin at home, either independently or with help from a trained caregiver. A New Direction for TED Care Thyroid eye disease is an immune-driven disorder linked to thyroid dysfunction. It can lead to inflamed and swollen eye tissues, bulging eye